-
Mashup Score: 7Newest research in sarcoma - 9 hour(s) ago
Sarcomas are a broad group of cancers that originate from connective tissues, such as the blood or lymph vessels, gastrointestinal tract, fat tissue, tendons, smooth muscles and tissue around the joints. Learn about the latest research on treating sarcomas.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8MD Anderson Research Highlights: ASCO 2024 Special Edition - 9 hour(s) ago
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet-
The Phase III SYMPATICO trial, led by our Dr. Michael Wang, demonstrated improved safety and efficacy of the targeted therapy combination (ibrutinib and venetoclax) compared with ibrutinib plus placebo in patients with relapsed/refractory MCL. Learn more: https://t.co/mNzPML9Awy… https://t.co/FbtkPQttKQ https://t.co/BIWqyin5Tk https://t.co/g4o93rOrVq
-
-
Mashup Score: 1Cancerwise Podcast - 10 hour(s) ago
MD Anderson’s Cancerwise podcast will feature insights from our experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories from survivors and caregivers who’ve faced cancer firsthand.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 31ASCO: Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors - 15 hour(s) ago
Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The University of Texas MD Anderson Cancer Center demonstrate promising responses and safety profiles in heavily pretreated patients with advanced solid tumors. The studies were featured in an oral abstract session highlighting the development of new molecularly targeted agents. Information on all MD Anderson ASCO Annual Meeting content can be found at MDAnderson.org/ASCO.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Cancerwise Podcast - 15 hour(s) ago
MD Anderson’s Cancerwise podcast will feature insights from our experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories from survivors and caregivers who’ve faced cancer firsthand.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 31ASCO: Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors - 16 hour(s) ago
Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The University of Texas MD Anderson Cancer Center demonstrate promising responses and safety profiles in heavily pretreated patients with advanced solid tumors. The studies were featured in an oral abstract session highlighting the development of new molecularly targeted agents. Information on all MD Anderson ASCO Annual Meeting content can be found at MDAnderson.org/ASCO.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 55MD Anderson at ASCO - 20 hour(s) ago
At MD Anderson, we work in partnership with our patients to enable groundbreaking research to better prevent, diagnose and treat cancer. Grounded in a culture of collaboration, connectivity and data-based science, our research yields transformative findings that are shifting patient care and improving patients’ lives across the globe. At the 2024 ASCO® Annual Meeting, our experts will showcase their pacesetting research and join colleagues for discussion on the latest advances in oncology. Below are
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 34What’s new in leukemia research? - 22 hour(s) ago
Fadi Haddad, M.D., assistant professor of Leukemia, walked us through a few updates in leukemia research being presented at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO).
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 53ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia - 2 day(s) ago
Researchers from The University of Texas MD Anderson Cancer Center presented positive clinical results from two studies today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The findings highlight strong remission and response rates and offer insights into improving treatment options for relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) and acute myeloid leukemia (AML) in older or chemotherapy-ineligible patients. Information on all ASCO Annual Meeting content from MD Anderson can be found at MDAnderson.org/ASCO.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6What happens to your lungs from smoking? 3 things to know - 2 day(s) ago
What does smoking do to the lungs? Tobacco addiction expert Dr. Maher Karam-Hage, weighs in.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet
“There is still more we can do to improve therapeutics for sarcoma,” says our Dr. Anthony Conley. Read about our new #sarcoma research being presented at #ASCO24: https://t.co/2CTuPRqEv9 @APConley77 @NassifElise @RyanDenu @GorlickRichard @dejkaaraujomd @CrisyRoland #EndCancer